Multiple risk factor intervention in type 2 diabetes: an opportunity not to be missed.
Cockcroft
J R
JR
Department of Cardiology, Wales Heart Research Institute, University Hospital, Cardiff CF4 4XN, UK. cockcroftjr@cf.ac.uk
Wilkinson
I B
IB
Yki-Järvinen
H
H
D001241:Aspirin / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D004730:Endothelium, Vascular / Q000503:physiopathology; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D006973:Hypertension / Q000150:complications / Q000628:therapy; D018384:Oxidative Stress; D012307:Risk Factors
D001241:Aspirin